CN100348208C - 中药制剂昆明山海棠水煎醇沉的制备方法 - Google Patents
中药制剂昆明山海棠水煎醇沉的制备方法 Download PDFInfo
- Publication number
- CN100348208C CN100348208C CNB200510057081XA CN200510057081A CN100348208C CN 100348208 C CN100348208 C CN 100348208C CN B200510057081X A CNB200510057081X A CN B200510057081XA CN 200510057081 A CN200510057081 A CN 200510057081A CN 100348208 C CN100348208 C CN 100348208C
- Authority
- CN
- China
- Prior art keywords
- preparation
- thundergodvine
- whiteback
- water decoction
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 52
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 title claims abstract description 50
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 title claims abstract description 40
- 241000887125 Chaptalia nutans Species 0.000 title claims description 17
- 238000001556 precipitation Methods 0.000 title claims description 17
- 235000015398 thunder god vine Nutrition 0.000 title claims description 17
- 238000000034 method Methods 0.000 title abstract description 13
- 239000003814 drug Substances 0.000 claims abstract description 25
- 239000002994 raw material Substances 0.000 claims abstract description 8
- 241001197778 Tripterygium hypoglaucum Species 0.000 claims description 53
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims description 22
- 229920002472 Starch Polymers 0.000 claims description 11
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 claims description 11
- 235000019359 magnesium stearate Nutrition 0.000 claims description 11
- 239000008107 starch Substances 0.000 claims description 11
- 235000019698 starch Nutrition 0.000 claims description 11
- 238000010438 heat treatment Methods 0.000 claims description 10
- 239000008187 granular material Substances 0.000 claims description 6
- 239000006187 pill Substances 0.000 claims description 6
- 238000001035 drying Methods 0.000 claims description 5
- 239000007788 liquid Substances 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 5
- 238000003756 stirring Methods 0.000 claims description 5
- 239000002775 capsule Substances 0.000 claims description 3
- -1 micropill Substances 0.000 claims description 3
- 239000003826 tablet Substances 0.000 claims description 3
- 231100000419 toxicity Toxicity 0.000 abstract description 10
- 230000001988 toxicity Effects 0.000 abstract description 10
- 239000003018 immunosuppressive agent Substances 0.000 abstract description 6
- 238000004519 manufacturing process Methods 0.000 abstract description 3
- 238000000605 extraction Methods 0.000 abstract description 2
- 235000019441 ethanol Nutrition 0.000 abstract 2
- 241000218999 Begoniaceae Species 0.000 abstract 1
- 238000000151 deposition Methods 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 229940125721 immunosuppressive agent Drugs 0.000 abstract 1
- 238000010992 reflux Methods 0.000 abstract 1
- 238000002481 ethanol extraction Methods 0.000 description 18
- 238000004062 sedimentation Methods 0.000 description 15
- 230000002401 inhibitory effect Effects 0.000 description 9
- 238000001914 filtration Methods 0.000 description 6
- 241001465754 Metazoa Species 0.000 description 5
- 229960003444 immunosuppressant agent Drugs 0.000 description 5
- 230000001861 immunosuppressant effect Effects 0.000 description 5
- 231100000331 toxic Toxicity 0.000 description 5
- 230000002588 toxic effect Effects 0.000 description 5
- 241000699666 Mus <mouse, genus> Species 0.000 description 4
- 241000699670 Mus sp. Species 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 230000001506 immunosuppresive effect Effects 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 206010028851 Necrosis Diseases 0.000 description 3
- 230000008485 antagonism Effects 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 230000004856 capillary permeability Effects 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 210000003494 hepatocyte Anatomy 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 230000017074 necrotic cell death Effects 0.000 description 3
- 229920000742 Cotton Polymers 0.000 description 2
- 208000009386 Experimental Arthritis Diseases 0.000 description 2
- 206010018691 Granuloma Diseases 0.000 description 2
- 231100000111 LD50 Toxicity 0.000 description 2
- 229930013930 alkaloid Natural products 0.000 description 2
- 150000003797 alkaloid derivatives Chemical class 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 210000002149 gonad Anatomy 0.000 description 2
- 210000002216 heart Anatomy 0.000 description 2
- 238000002513 implantation Methods 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 210000000265 leukocyte Anatomy 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- PFTAWBLQPZVEMU-ZFWWWQNUSA-N (+)-epicatechin Natural products C1([C@@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-ZFWWWQNUSA-N 0.000 description 1
- PFTAWBLQPZVEMU-UKRRQHHQSA-N (-)-epicatechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-UKRRQHHQSA-N 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 208000023275 Autoimmune disease Diseases 0.000 description 1
- VYZAHLCBVHPDDF-UHFFFAOYSA-N Dinitrochlorobenzene Chemical compound [O-][N+](=O)C1=CC=C(Cl)C([N+]([O-])=O)=C1 VYZAHLCBVHPDDF-UHFFFAOYSA-N 0.000 description 1
- 206010018367 Glomerulonephritis chronic Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- 206010047115 Vasculitis Diseases 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 210000004100 adrenal gland Anatomy 0.000 description 1
- 230000004520 agglutination Effects 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 206010003883 azoospermia Diseases 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- LPTRNLNOHUVQMS-UHFFFAOYSA-N epicatechin Natural products Cc1cc(O)cc2OC(C(O)Cc12)c1ccc(O)c(O)c1 LPTRNLNOHUVQMS-UHFFFAOYSA-N 0.000 description 1
- 235000012734 epicatechin Nutrition 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 230000007866 hepatic necrosis Effects 0.000 description 1
- 206010019692 hepatic necrosis Diseases 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 206010025135 lupus erythematosus Diseases 0.000 description 1
- 210000000865 mononuclear phagocyte system Anatomy 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 208000008634 oligospermia Diseases 0.000 description 1
- 230000036616 oligospermia Effects 0.000 description 1
- 231100000528 oligospermia Toxicity 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 231100000456 subacute toxicity Toxicity 0.000 description 1
- 206010043554 thrombocytopenia Diseases 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
提取方法 | 小鼠 | LD50值(生药g/kg) |
昆明山海棠水煎醇沉制剂 | 国家标准 | 68 |
昆明山海棠50%乙醇提取物 | 国家标准 | 39.81 |
制剂 | 剂量(g/kg/日×5) | 鼠耳增重(mg) |
生理盐水 | -- | 6.93±0.91 |
昆明山海棠片(水煎醇沉) | 30 | 1.23±0.30 |
昆明山海棠50%乙醇提取物 | 10 | 3.75±0.39 |
制剂 | 剂量(g/kg/日×4) | 鼠耳增重(mg) |
生理盐水 | -- | 0.0559±0.0128 |
昆明山海棠片(水煎醇沉) | 30 | 0.0259±0.0065 |
昆明山海棠50%乙醇提取物 | 5 | 0.0312±0.0065 |
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB200510057081XA CN100348208C (zh) | 2005-05-23 | 2005-05-23 | 中药制剂昆明山海棠水煎醇沉的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB200510057081XA CN100348208C (zh) | 2005-05-23 | 2005-05-23 | 中药制剂昆明山海棠水煎醇沉的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1698772A CN1698772A (zh) | 2005-11-23 |
CN100348208C true CN100348208C (zh) | 2007-11-14 |
Family
ID=35475125
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB200510057081XA Active CN100348208C (zh) | 2005-05-23 | 2005-05-23 | 中药制剂昆明山海棠水煎醇沉的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100348208C (zh) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102727558A (zh) * | 2012-07-04 | 2012-10-17 | 重庆市中药研究院 | 一种火把花根提取物、双层缓释片及其应用 |
CN105213463A (zh) * | 2015-11-18 | 2016-01-06 | 重庆市中药研究院 | 一种用于湿疹的火把花根外用制剂、制备方法及其应用 |
CN105250348B (zh) * | 2015-11-18 | 2019-05-14 | 重庆市中药研究院 | 一种用于消肿止痛的火把花根外用制剂、制备方法及其应用 |
CN105250349A (zh) * | 2015-11-18 | 2016-01-20 | 重庆市中药研究院 | 一种用于类风湿关节炎的火把花根巴布贴剂、制备方法及其应用 |
CN107184633A (zh) * | 2017-06-08 | 2017-09-22 | 重庆市药研院制药有限公司 | 火把花根浸膏的醇沉制备方法 |
CN113713005A (zh) * | 2020-11-24 | 2021-11-30 | 重庆市药研院制药有限公司 | 一种火把花根片的制备方法及制得的火把花根片 |
-
2005
- 2005-05-23 CN CNB200510057081XA patent/CN100348208C/zh active Active
Non-Patent Citations (2)
Title |
---|
中药药剂学 106.107,上海科学技术出版社 1997 * |
昆明山海棠水提液的急性毒性研究 杨录军,余厚勇等.第三军医大学学报,第25卷第17期 2003 * |
Also Published As
Publication number | Publication date |
---|---|
CN1698772A (zh) | 2005-11-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102258563B (zh) | 一种抗癌药物组合物和一种中药组合物 | |
CN100348208C (zh) | 中药制剂昆明山海棠水煎醇沉的制备方法 | |
CN101234141B (zh) | 金不换总生物碱及其制备方法和应用 | |
CN102397372A (zh) | 一种药物组合物及制剂和其在治疗肠易激综合征中的应用 | |
CN101810715A (zh) | 吴茱萸及其提取物、化合物的新用途 | |
CN111494564B (zh) | 一种复合型保肝解酒片的制备方法 | |
CN101167863B (zh) | 一种治疗糖尿病肾病的中成药及其制备方法 | |
CN112439018A (zh) | 具有减肥降脂的组合物及其制备方法和应用 | |
CN102526668A (zh) | 用于减少癌症化疗引起的呕吐并对化疗增效的生姜与白胡椒组合物及其制备方法 | |
CN107375430A (zh) | 一种具有防治糖尿病及并发症的姜黄素组合物 | |
CN103908484A (zh) | 一种用于治疗类风湿性关节炎的雷公藤涂膜剂及其制备方法 | |
CN100548308C (zh) | 用于自身免疫性疾病和器官移植排异的药物组合物 | |
CN100457147C (zh) | 一种治疗妇女更年期综合征的中药组合物及制备方法 | |
CN101670007B (zh) | 一种预防和治疗肾脏疾病的药物及其制备方法 | |
CN1318034C (zh) | 用桑白皮提取物制备的药物制剂 | |
CN100360164C (zh) | 治疗糖尿病的药物及其制备方法 | |
CN101554399B (zh) | 一种具有免疫增强作用的补骨脂提取物及应用 | |
CN104510857B (zh) | 一种用于降脂的中药有效部位组合物及其制剂 | |
CN102631418B (zh) | 一种消炎、镇痛中药提取物及其制备方法 | |
CN115364179B (zh) | 一种降低血尿酸的中药组合物及其制备方法与应用 | |
CN102552481A (zh) | 一种通络降压中药组合物及其制备方法 | |
CN101991678B (zh) | 茜草在制备预防和治疗肾脏疾病的药物方面的应用 | |
CN100352478C (zh) | 中药山药的制药新用途 | |
CN102973843A (zh) | 一种养阴清肺、化痰利咽的中药复方提取物及其制剂 | |
CN103908481A (zh) | 楷木与四叶参提取物对癌化疗的减毒增效用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee |
Owner name: CHONGQING PHARMACEUTICAL RESEARCH INSTITUTE PHARMA Free format text: FORMER NAME: PHARMACEUTICAL FACTORY, CHONGQING CITY INST. OF CHINESE MEDICINE |
|
CP01 | Change in the name or title of a patent holder |
Address after: Huang Jueya South Road 400065 Chongqing Nan'an District No. 34 Patentee after: Chongqing Pharmaceutical Research Institute Pharmaceutical Co.,Ltd. Address before: Huang Jueya South Road 400065 Chongqing Nan'an District No. 34 Patentee before: Chongqing Academy of Chinese Materia Medica Pharmaceutical Factory |
|
CP02 | Change in the address of a patent holder |
Address after: 400800 Chongqing city Wansheng District East Qingxi Bridge No. 303 of No. 10 Patentee after: Chongqing Pharmaceutical Research Institute Pharmaceutical Co.,Ltd. Address before: Huang Jueya South Road 400065 Chongqing Nan'an District No. 34 Patentee before: Chongqing Pharmaceutical Research Institute Pharmaceutical Co.,Ltd. |
|
CP02 | Change in the address of a patent holder | ||
CP02 | Change in the address of a patent holder |
Address after: 400000 Zhongke Future City, Xinshi Street, Changshou District, Chongqing Patentee after: Chongqing Pharmaceutical Research Institute Pharmaceutical Co.,Ltd. Address before: 400800 No. 303, Qingxi bridge, Donglin, Wansheng District, Chongqing, 10 Patentee before: Chongqing Pharmaceutical Research Institute Pharmaceutical Co.,Ltd. |
|
CP02 | Change in the address of a patent holder | ||
CP03 | Change of name, title or address |
Address after: No. 10 Bitong Road, Xinshi Street, Changshou District, Chongqing 401220 Patentee after: Chongqing Pharmaceutical Research Institute Pharmaceutical Co.,Ltd. Address before: 401220 Zhongke Future City, Xinshi Street, Changshou District, Chongqing Patentee before: Chongqing Pharmaceutical Research Institute Pharmaceutical Co.,Ltd. |
|
CP03 | Change of name, title or address |